Public COA audit

Tirzepatide

Audited September 5, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
72
Confidence
88%
Panels
2/7
Purity (printed)
99.8%

Scored moderately because the document is mostly consistent but carries soft concerns, limited panel coverage (2/7), 1 critical finding, and notable note: "High HPLC purity". To improve: include identity, purity, and endotoxin at minimum.

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
PPJXN5Y
Identity method
FTIR (USP <197A>)
Sample date
2026-06-04
Issue date
2026-06-06

Original certificate

Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.

Loading original certificate…

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

2 of 7 present · 2 passed · 0 failed · 0 reported · 5 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    FTIR sample spectrum confirms the presence of Tirzepatide with addition of excipient(s)/fillers

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.8%

  • Heavy metals

    Not on this certificate file

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Microbial

    Not on this certificate file

    Bioburden / microbial limits testing.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Endotoxin

    Not on this certificate file · core

    LAL or chromogenic endotoxin assay.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Sterility

    Not on this certificate file

    Sterility testing where applicable.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Residual solvent / water

    Not on this certificate file

    Residual solvents or water content limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing on this file

Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High HPLC purity

    99.8% purity by HPLC is excellent and typical for research-grade peptides

  • FTIR identity confirmed

    FTIR spectrum confirms Tirzepatide presence with excipients/fillers noted

  • Potency significantly below label claim

    HPLC potency assay shows 20.8 mg (41.6%) versus labeled 50 mg claim. This is a major deviation from the 90-110% specification and indicates the vial contains less than half the stated peptide content

  • Limited testing scope

    Testing Purpose explicitly states this does NOT provide information on particulate matter, microbial contamination, or presence of endotoxins. This is a purity/identity-scoped report only

  • Batch information complete

    Lot number PPJXN5Y clearly stated with BT Sample ID 005000040282952

  • Dates are valid

    Sample tested 2026-06-04, report issued 2026-06-06 (both on or before current date 2026-09-05)

  • Testing lab identified

    BTLabs (BT Lab Testing), West Palm Beach, FL with contact information and digital signatures from two scientists

  • Professional presentation

    Report includes FTIR spectrum, HPLC chromatogram, digital signatures, and follows standard COA format with USP method references

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.